The data on what happens after you stop is worse than anyone selling you the injection wants you to know.
Fernando Olivares
Dot Fer | ProductFitCoach
Sept 3rd, 2026
Everyone's on one now, or thinking about it, or knows someone who is.
Ozempic, Wegovy, Mounjaro, Zepbound, whatever brand you want to name. And I get why: Perceived simplicity.
You inject this weekly, and your appetite disappears, the weight comes off, and suddenly you don't have to think about food anymore.
That's exactly the problem.
Ozempic 1 mg and injection.
You didn't fix your relationship with food. You silenced it.
A lot of smart, otherwise skeptical people are choosing not to look too closely at that distinction, because looking closely means admitting the easy version isn't working long term.
The number on the scale going down feels like progress, and that's the trap. It's the easiest metric out there to be obsessed with, and one of the worst ones to trust blindly. And that's how a lot of modern medicine feels to me. Get a number down, mark it as a win, move on.
High blood pressure, you've got a pill. Overweight? Here's the injection. What almost never happens is a specialized person staying with you long enough to fix why the number got there in the first place. That part takes time and consistency, and it's a different job than writing a prescription.
And… what actually happens when the thing making your food decisions for you stops working?
That's not a rhetorical question. There's real data on it. And almost nobody talking about these drugs online has actually read past the headline.
This Isn't a One-Off Finding, and That's the Part That Should Worry You
Let's start with the trial that made this whole category famous. The extension of STEP 1, the same study that got semaglutide (Wegovy) approved.
Participants lost an average of 17.3% of body weight over 68 weeks. One year after stopping the drug and the lifestyle coaching that came bundled with it, they had regained two thirds of that loss. Net result after two years: 5.6% down instead of 17.3% (Wilding et al., Diabetes, Obesity and Metabolism, 2022).
Both groups stopped treatment after week 68 — the semaglutide arm still ended up back near where the never-treated placebo arm had been the whole time. Source: Wilding et al., Diabetes, Obesity and Metabolism, 2022 (STEP 1 trial extension).
If that were the only study out there, you could call it a coincidence of one drug or one group of people. But it isn't. A 2025 review pooling multiple randomized trials of GLP-1 drugs found the same pattern across the board, in weight, waist size, blood sugar, and blood pressure, every time the drug came off.
Tirzepatide, the newer, stronger version behind Mounjaro and Zepbound, doesn't escape this either. In the SURMOUNT-4 trial, people who switched from tirzepatide to placebo regained 14% of their body weight on average over the next year, while the group that stayed on the drug kept losing.
Patients who switched to placebo regained more than half the weight they'd lost within a year. Those who stayed on tirzepatide kept losing. Source: Aronne et al., JAMA, 2024 (SURMOUNT-4).
A more recent look at that same trial is even harder to argue with: most people who had the drug taken away regained at least a quarter of their prior weight loss within twelve months, and a real chunk of the health improvements they'd gained went with it (Aronne et al., JAMA, 2024; Horn et al., JAMA Internal Medicine, 2026).
And this isn't "some people regain a bit of weight." This is the expected, well documented, repeatedly confirmed outcome. If something failed this consistently across this many independent studies, nobody would call it a success story.
And here's the part worth sitting with. The drug does work, and nobody's disputing that. But take it away, whether that's a trial swapping in placebo or real life where you stop injecting, and the body goes right back to where it started.
Which leads to the question:
Are you signing up to taking this stuff forever?
Because that's what "working" looks like from this point on, switching on and off from it, and almost nobody frames it that way when you start.
The Muscle Problem Nobody's Marketing
Research looking at body composition on these drugs found that muscle, not fat, made up roughly a quarter of the total weight people lost on average. Some studies put that figure as high as 40 to 60%, depending on the specific drug, the dose, and whether the person was doing any strength training at all (Neeland et al., Diabetes, Obesity and Metabolism, 2024).
Read that again.
Up to 60% of what you're losing on some of these can be lean mass, muscle, water or connective tissue.
Muscle is what keeps your metabolism running, your joints stable, your grip strong. It's what keeps your body capable at 55 instead of frail.
Lose a big chunk of it while the scale drops, then regain most of the weight once you stop the drug, and you can land in a worse spot than where you started. Heavier, weaker, with less muscle to show for the whole thing. That's not scaremongering. That's just what the data shows, and it's rarely part of the conversation when someone's deciding to start.
What I'd Actually Focus On If I Were On One
Here's the thing none of this fixes on its own: the drug quiets your appetite, but it doesn't touch why you were eating that way to begin with. Stress, boredom, a bad day, using food to feel better instead of dealing with the actual thing. That part is still there, waiting, for whenever the injection stops doing the work for you.
So if I were on a GLP-1, or thinking about starting one, here's what I'd spend that quiet window actually doing:
Learn what real food and real portions look like. Not a tracker or the injection doing that thinking for me. Just knowing what a normal, healthy, breakfast, lunch or dinner plate looks like.
Lift weights, consistently. With less appetite comes less muscle at risk if you're not training. Strength training is the one thing that pushes back against that.
Build a small rotation of meals I don't have to think about. Decision fatigue is what breaks most people, not a lack of information. Eating similar meals helps with that.
Do the mental work. Figure out what's actually driving the eating, stress, boredom, a bad day, before the appetite comes back and starts making decisions for me again. This is the piece that decides whether any of this holds once the drug stops carrying the weight.
To be clear, this isn't an anti-medication take. For people dealing with serious obesity, a GLP-1 can be a legitimate, sometimes lifesaving tool. My issue is only with treating it as the whole plan instead of an assist.
Do the work while you have the leverage, so the day you come off it, you're not starting from zero.
Ready to build something that actually holds? Here's two ways I can help:
Are you a founder or senior tech leader who wants to improve your health while getting in shape, increasing your energy and focus? Let's speak! Book a Free Strategy Call with me here.
FitDots: The first Fitness Plan really designed for busy professionals. You will get 15-to-45 min workouts without a gym + The Lean Nutrition System. Perfect to lose weight, gain muscle and boost your cognitive performance. Get your Time-Flexible fitness plan here.
References
This content is for educational and informational purposes only and does not constitute medical or nutritional advice. Talk to your doctor before starting or stopping any medication.